Biontech Se Stock Alpha and Beta Analysis
| BNTX Stock | USD 99.47 2.00 2.05% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as BioNTech SE. It also helps investors analyze the systematic and unsystematic risks associated with investing in BioNTech over a specified time horizon. Remember, high BioNTech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BioNTech's market risk premium analysis include:
Beta 0.91 | Alpha (0.13) | Risk 3.23 | Sharpe Ratio (0.06) | Expected Return (0.18) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
BioNTech |
BioNTech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BioNTech market risk premium is the additional return an investor will receive from holding BioNTech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BioNTech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BioNTech's performance over market.| α | -0.13 | β | 0.91 |
BioNTech expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of BioNTech's Buy-and-hold return. Our buy-and-hold chart shows how BioNTech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.BioNTech Market Price Analysis
Market price analysis indicators help investors to evaluate how BioNTech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioNTech shares will generate the highest return on investment. By understating and applying BioNTech stock market price indicators, traders can identify BioNTech position entry and exit signals to maximize returns.
BioNTech Return and Market Media
The median price of BioNTech for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 115.79 with a coefficient of variation of 5.01. The daily time series for the period is distributed with a sample standard deviation of 5.81, arithmetic mean of 115.77, and mean deviation of 4.48. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | BioNTechs Big Moves 1.2 Billion Settlements and a Game-Changing Cancer Bet | 12/27/2024 |
2 | 3 Dirt-Cheap Stocks to Buy in a Market Thats Priced for Perfection | 01/22/2025 |
3 | Electronic Arts Posts Upbeat Earnings, Joins Mattel, Johnson Controls, Mueller Water Products And Other Big Stocks Moving Higher On Wednesday | 02/05/2025 |
4 | The 7.2 percent return this week takes BioNTechs shareholders five-year gains to 271 | 02/19/2025 |
5 | BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on ... | 02/24/2025 |
6 | Quinn Opportunity Partners LLC Increases Stake in Childrens Place Inc | 02/25/2025 |
7 | Pfizer Incs Strategic Acquisition of Haleon PLC Shares | 02/27/2025 |
8 | Health Care Stocks Rise -- Health Care Roundup | 03/05/2025 |
9 | Nasdaq Falls Into Correction As Tariffs Roil Wall Street Whats Moving Markets Friday | 03/07/2025 |
10 | Pfizers COVID-19 Shot Partner BioNTech Reports Q4 Profit, But 2025 Guidance Falls Short On Expectations | 03/10/2025 |
11 | BioNTech SE Q4 2024 Earnings Call Transcript | 03/11/2025 |
12 | Citi says SMid biotechs alternative to large caps as it starts coverage | 03/13/2025 |
About BioNTech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BioNTech or other stocks. Alpha measures the amount that position in BioNTech SE has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Dividend Yield | 0.0123 | 0.011 | Price To Sales Ratio | 9.5 | 9.02 |
BioNTech Upcoming Company Events
As portrayed in its financial statements, the presentation of BioNTech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioNTech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of BioNTech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of BioNTech. Please utilize our Beneish M Score to check the likelihood of BioNTech's management manipulating its earnings.
| 25th of March 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 25th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with BioNTech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for BioNTech Stock Analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.